LXRX
Lexicon Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +25.0% ·
Aktienfluss -0.7% ·
neue Nettopositionen +20.0%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +16 | 115.42M | $276.97M | +20 | −4 |
| Q1 2026 | 53 | +1 | 96.42M | $150.42M | +5 | −4 |
| Q4 2025 | 51 | +1 | 73.64M | $84.69M | +2 | −1 |
| Q3 2025 | 13 | 0 | 62.78M | $84.76M | +2 | −2 |
| Q2 2025 | 10 | +2 | 57.50M | $54.38M | +4 | −2 |
| Q1 2025 | 5 | -2 | 7.56M | $3.49M | +1 | −3 |
| Q4 2024 | 7 | -2 | 16.13M | $11.91M | +1 | −3 |
| Q3 2024 | 8 | 0 | 7.88M | $12.37M | — | — |
| Q2 2024 | 8 | — | 12.44M | $20.91M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 38.14M | — | $36.07M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 38.14M | — | $36.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 38.14M | — | $36.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passiv) | 8.85M | — | $8.37M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passiv) | 8.85M | — | $8.37M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 3.35M | — | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 3.35M | — | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 3.35M | — | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 2.38M | -35.5% | $2.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 2.38M | -35.5% | $2.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.64M | Neu | $1.55M | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.40M | +19.5% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passiv) | 818.62K | -68.6% | $774,170 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 486.67K | Neu | $460,248 | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 486.67K | Neu | $460,248 | 0.0% | New | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 486.67K | Neu | $460,248 | 0.0% | New | 1 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 403.92K | Neu | $381,989 | 0.0% | New | 1 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 23.72K | Neu | $22,435 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Millennium Management | $1.55M | 0.0% |
| Wellington Management | $460,248 | 0.0% |
| Wellington Management | $460,248 | 0.0% |
| Wellington Management | $460,248 | 0.0% |
| Two Sigma Investments | $381,989 | 0.0% |
| D. E. Shaw & Co. | $22,435 | 0.0% |
Ausgestiegen
| T. Rowe Price | $43,000 | war 0.0% |
| Citadel Advisors | $187 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 136 Inhaber, 323.38M Anteile, $502.11M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.